Literature DB >> 8067142

[The new chemical preparation arbidol: its prophylactic efficacy during influenza epidemics].

V M Gagarinova, G S Ignat'eva, L V Sinitskaia, A M Ivanova, M A Rodina, A V Tur'eva.   

Abstract

In four controlled observations on the organized groups of students and industrial workers during the epidemics of influenza A in 1988-1989 Arbidol, a new chemopreparation, was found to be well tolerated and to produce a pronounced prophylactic effect when administered in a dose of 0.2 g (2 tablets of 0.1 g) daily for 10-18 days. After the 18-day prophylactic course of Arbidol the induction of serum interferon was found.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8067142

Source DB:  PubMed          Journal:  Zh Mikrobiol Epidemiol Immunobiol        ISSN: 0372-9311


  11 in total

1.  Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol.

Authors:  Eve-Isabelle Pécheur; Dimitri Lavillette; Fanny Alcaras; Jennifer Molle; Yury S Boriskin; Michael Roberts; François-Loïc Cosset; Stephen J Polyak
Journal:  Biochemistry       Date:  2007-04-25       Impact factor: 3.162

2.  The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses.

Authors:  Eve-Isabelle Pécheur; Viktoriya Borisevich; Peter Halfmann; John D Morrey; Donald F Smee; Mark Prichard; Chad E Mire; Yoshihiro Kawaoka; Thomas W Geisbert; Stephen J Polyak
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

Review 3.  Iminosugars: Promising therapeutics for influenza infection.

Authors:  Beatrice Ellen Tyrrell; Andrew Cameron Sayce; Kelly Lyn Warfield; Joanna Louise Miller; Nicole Zitzmann
Journal:  Crit Rev Microbiol       Date:  2016-12-08       Impact factor: 7.624

4.  Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals.

Authors:  Chunguang Yang; Chunjin Ke; Daoyuan Yue; Wengang Li; Zhiquan Hu; Wei Liu; Shuhua Hu; Shaogang Wang; Jihong Liu
Journal:  Front Public Health       Date:  2020-05-29

Review 5.  Current and Novel Approaches in Influenza Management.

Authors:  Erasmus Kotey; Deimante Lukosaityte; Osbourne Quaye; William Ampofo; Gordon Awandare; Munir Iqbal
Journal:  Vaccines (Basel)       Date:  2019-06-18

Review 6.  Arbidol as a broad-spectrum antiviral: an update.

Authors:  Julie Blaising; Stephen J Polyak; Eve-Isabelle Pécheur
Journal:  Antiviral Res       Date:  2014-04-24       Impact factor: 5.970

7.  Antiviral Abidol is Associated with the Reduction of In-Hospital Mortality in COVID-19 Patients.

Authors:  Hesong Zeng; Xingwei He; Wanjun Liu; Jing Kan; Liqun He; Jinhe Zhao; Cynthia Chen; Junjie Zhang; Shaoliang Chen
Journal:  Cardiol Discov       Date:  2021-12-03

Review 8.  Current Strategies for Inhibition of Chikungunya Infection.

Authors:  Bharat Bhusan Subudhi; Soma Chattopadhyay; Priyadarsee Mishra; Abhishek Kumar
Journal:  Viruses       Date:  2018-05-03       Impact factor: 5.048

9.  Metabolite identification of arbidol in human urine by the study of CID fragmentation pathways using HPLC coupled with ion trap mass spectrometry.

Authors:  Yuya Wang; Xiaoyan Chen; Qiang Li; Dafang Zhong
Journal:  J Mass Spectrom       Date:  2008-08       Impact factor: 1.982

Review 10.  Structural Biology of Influenza Hemagglutinin: An Amaranthine Adventure.

Authors:  Nicholas C Wu; Ian A Wilson
Journal:  Viruses       Date:  2020-09-22       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.